questionText: To ask the Secretary of State for Health and Social Care, if he will take steps to increase the availability of Produodopa for people with Parkinson’s disease in Newcastle-under-Lyme constituency.
answerText: The National Institute for Health and Care Excellence (NICE) published guidance recommending foslevodopa–foscarbidopa (Produodopa) for patients with Parkinson’s disease meeting specified clinical criteria, in November 2023. Produodopa is now available to ...
heading: Parkinson's Disease: Newcastle-under-Lyme